|
|
||||||||
Ann Thorac Surg 1984;38:554-562
© 1984 The Society of Thoracic Surgeons
Department of Cardiovascular Surgery, Stanford University Medical Center, Stanford, CA
* Address reprint requests to Dr. Jamieson, Department of Cardiovascular Surgery, Stanford University Medical Center, Stanford, CA 94305
Combined heart and lung transplantation was carried out in 17 patients at Stanford University between March, 1981, and December, 1983. The recipients were between 22 and 45 years old. All patients had end-stage pulmonary hypertension; 10 had Eisenmenger's syndrome and the remaining 7, primary pulmonary hypertension. Five patients died within the first few postoperative weeks. The remainder are well between four weeks and 33 months from operation.
The immunosuppressive protocol has consisted of cyclosporine with an initial course of rabbit antithymocyte globulin. Azathioprine also was given for the first two weeks and then was replaced with prednisone. Rejection, as diagnosed by cardiac biopsy, was treated with high doses of methylprednisolone. Modifications of technique that have developed include the removal of the recipient heart and lungs separately, and preservation of the lungs with a modified Collins' solution instead of a cardioplegic solution.
Rejection occurred in 6 of the 12 survivors. Infections developed in 9 patients, but only one resulted in a fatal outcome (Legionella). Thus, the results of clinical heart-lung transplantation have been considerably superior to clinical efforts in lung transplantation. It is suggested that the combined operation is preferable for the following reasons: (1) all diseased tissue is removed, thus eliminating recurrent infection and ventilation/perfusion disparity; (2) transplantation of the entire heart-lung block preserves coronary–bronchial vascular anastomoses and makes airway dehiscence less likely; and (3) to date, diagnosis of rejection by cardiac biopsy has appeared to be a satisfactory method of diagnosing and treating pulmonary rejection. Cardiopulmonary transplantation represents a viable therapeutic approach for patients with end-stage pulmonary hypertension with or without associated congenital heart disease.
This article has been cited by other articles:
![]() |
S. W. Hirt, A. Haverich, T. Wahlers, H.-J. Schafers, A. Alken, and H.-G. Borst Predictive criteria for the need of extracorporeal circulation in single-lung transplantation Ann. Thorac. Surg., October 1, 1992; 54(4): 676 - 680. [Abstract] [PDF] |
||||
![]() |
C.-M. Hsieh, G. J. Mishkel, P. F. G. Cardoso, H. Rakowski, S. C. Dunn, J. Butany, R. D. Weisel, G. A. Patterson, and J. D. Cooper Production and reversibility of right ventricular hypertrophy and right heart failure in dogs Ann. Thorac. Surg., July 1, 1992; 54(1): 104 - 110. [Abstract] [PDF] |
||||
![]() |
S. W. Hirt, T. Wahlers, M. J. Jurmann, L. Dammenhayn, J. Kemnitz, R. Rohde, and A. Haverich University of Wisconsin versus modified Euro-Collins solution for lung preservation Ann. Thorac. Surg., January 1, 1992; 53(1): 74 - 79. [Abstract] [PDF] |
||||
![]() |
R. J. Novick, A. H. Menkis, F. N. McKenzie, K. R. Reid, P. W. Pflugfelder, W. J. Kostuk, and D. Ahmad The safety of low-dose prednisone before and immediately after heart-lung transplantation Ann. Thorac. Surg., April 1, 1991; 51(4): 642 - 645. [Abstract] [PDF] |
||||
![]() |
B. P. Griffith, R. L. Hardesty, A. Trento, I. L. Paradis, R. J. Duquesnoy, A. Zeevi, J. H. Dauber, J. S. Dummer, M. E. Thompson, S. Gryzan, et al. Heart-Lung Transplantation: Lessons Learned and Future Hopes Ann. Thorac. Surg., January 1, 1987; 43(1): 6 - 16. [Abstract] [PDF] |
||||
![]() |
J. H. Dark, G. A. Patterson, A. N. Al-Jilaihawi, H. Hsu, T. Egan, and J. D. Cooper Experimental En Bloc Double-Lung Transplantation Ann. Thorac. Surg., October 1, 1986; 42(4): 394 - 398. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |